Tags

Type your tag names separated by a space and hit enter

Assessing the outcomes of mini-Monoka stent dilatation for primary punctal stenosis using the lacrimal symptom questionnaire.
Indian J Ophthalmol. 2018 02; 66(2):269-271.IJ

Abstract

PURPOSE

The objective of this study was to assess the quality of outcomes of mini-Monoka stent dilatation for punctal stenosis using the lacrimal symptom (Lac-Q) questionnaire.

METHODS

Prospective interventional case series of 45 eyes of 25 consecutive patients who underwent mini-Monoka stent dilatation for primary punctal stenosis were included in the study. The stents were extubated at 4 weeks. The Lac-Q questionnaire was administered preoperatively and at 12 weeks and 24 weeks following the intervention. Outcomes assessed were anatomical success, functional success, and changes in the questionnaire scores including total, social impact, and lacrimal symptom scores. Statistical analysis was performed using the Wilcoxon signed-rank test, and the probability of obtaining a certain score was calculated using the multinomial log-linear model. P < 0.05 was considered as significant.

RESULTS

Monoka stents were performed for 45 eyes. A total of 75 questionnaire responses were analyzed. At the last follow-up of 24 weeks, the anatomical and functional success rates were 93.3% (42/45). The changes in the mean total score (7.68 preoperatively to 0.82 at 24-week follow-up) were statistically significant (P ≤ 0.001). The mean social impact scores showed significant improvement postoperatively from 4.06 to 0.53 (P ≤ 0.001). The mean lacrimal symptom score changed from a preoperative value of 3.62 to 0.28 (P ≤ 0.001) at the last follow-up. Postoperative scoring correlated well with the anatomical and functional success rates. The symptom scores corroborated with changes in the clinical outcomes.

CONCLUSION

Mini-Monoka stent dilatation is a very effective intervention for the management of primary punctal stenosis, and Lac-Q questionnaire is a simple and useful tool to evaluate the quality of outcomes in such cases.

Authors+Show Affiliations

Govindram Seksaria Institute of Dacryology, L. V. Prasad Eye Institute, Hyderabad, Telangana, India.Govindram Seksaria Institute of Dacryology, L. V. Prasad Eye Institute, Hyderabad, Telangana, India.Center for Clinical Epidemiology and Biostatistics, L. V. Prasad Eye Institute, Hyderabad, Telangana, India.Govindram Seksaria Institute of Dacryology, L. V. Prasad Eye Institute, Hyderabad, Telangana, India.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

29380772

Citation

Gupta, Shweta, et al. "Assessing the Outcomes of mini-Monoka Stent Dilatation for Primary Punctal Stenosis Using the Lacrimal Symptom Questionnaire." Indian Journal of Ophthalmology, vol. 66, no. 2, 2018, pp. 269-271.
Gupta S, Ali MJ, Ali MH, et al. Assessing the outcomes of mini-Monoka stent dilatation for primary punctal stenosis using the lacrimal symptom questionnaire. Indian J Ophthalmol. 2018;66(2):269-271.
Gupta, S., Ali, M. J., Ali, M. H., & Naik, M. N. (2018). Assessing the outcomes of mini-Monoka stent dilatation for primary punctal stenosis using the lacrimal symptom questionnaire. Indian Journal of Ophthalmology, 66(2), 269-271. https://doi.org/10.4103/ijo.IJO_799_17
Gupta S, et al. Assessing the Outcomes of mini-Monoka Stent Dilatation for Primary Punctal Stenosis Using the Lacrimal Symptom Questionnaire. Indian J Ophthalmol. 2018;66(2):269-271. PubMed PMID: 29380772.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Assessing the outcomes of mini-Monoka stent dilatation for primary punctal stenosis using the lacrimal symptom questionnaire. AU - Gupta,Shweta, AU - Ali,Mohammad Javed, AU - Ali,Mohammad Hasnat, AU - Naik,Milind N, PY - 2018/1/31/entrez PY - 2018/1/31/pubmed PY - 2018/5/31/medline SP - 269 EP - 271 JF - Indian journal of ophthalmology JO - Indian J Ophthalmol VL - 66 IS - 2 N2 - PURPOSE: The objective of this study was to assess the quality of outcomes of mini-Monoka stent dilatation for punctal stenosis using the lacrimal symptom (Lac-Q) questionnaire. METHODS: Prospective interventional case series of 45 eyes of 25 consecutive patients who underwent mini-Monoka stent dilatation for primary punctal stenosis were included in the study. The stents were extubated at 4 weeks. The Lac-Q questionnaire was administered preoperatively and at 12 weeks and 24 weeks following the intervention. Outcomes assessed were anatomical success, functional success, and changes in the questionnaire scores including total, social impact, and lacrimal symptom scores. Statistical analysis was performed using the Wilcoxon signed-rank test, and the probability of obtaining a certain score was calculated using the multinomial log-linear model. P < 0.05 was considered as significant. RESULTS: Monoka stents were performed for 45 eyes. A total of 75 questionnaire responses were analyzed. At the last follow-up of 24 weeks, the anatomical and functional success rates were 93.3% (42/45). The changes in the mean total score (7.68 preoperatively to 0.82 at 24-week follow-up) were statistically significant (P ≤ 0.001). The mean social impact scores showed significant improvement postoperatively from 4.06 to 0.53 (P ≤ 0.001). The mean lacrimal symptom score changed from a preoperative value of 3.62 to 0.28 (P ≤ 0.001) at the last follow-up. Postoperative scoring correlated well with the anatomical and functional success rates. The symptom scores corroborated with changes in the clinical outcomes. CONCLUSION: Mini-Monoka stent dilatation is a very effective intervention for the management of primary punctal stenosis, and Lac-Q questionnaire is a simple and useful tool to evaluate the quality of outcomes in such cases. SN - 1998-3689 UR - https://www.unboundmedicine.com/medline/citation/29380772/Assessing_the_outcomes_of_mini_Monoka_stent_dilatation_for_primary_punctal_stenosis_using_the_lacrimal_symptom_questionnaire_ L2 - http://www.ijo.in/article.asp?issn=0301-4738;year=2018;volume=66;issue=2;spage=269;epage=271;aulast=Gupta DB - PRIME DP - Unbound Medicine ER -